Dr. Hong Li, professor in Van Andel Institute’s Department of Structural Biology, leverages CRISPR, cryo-EM and other leading-edge technologies to explore the mechanisms underlying RNA-mediated ...

Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...

Oceanic ecosystems are increasingly threatened by global warming, which causes coral bleaching, species migration and, ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

Nobel laureate Jennifer Doudna, PhD; Matthew Porteus, MD, PhD, and Rodolphe Barrangou, PhD—offer their views on the commercial potential and challenges of genome editing following a rollercoaster 2025 ...

The onset and aggressiveness of cancer are related to the abnormal behavior of certain genes, known as oncogenes. The best-known of these alterations is mutation, but it is not the only one. Sometimes ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...

CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations associated with the strategy, including off-target DNA editing. A group of ...

Gene-editing citrus fruits to make them less bitter could not only encourage more people to eat them, it might also help save the industry from a devastating plague ...

A small change to a powerful molecular tool — using the CRISPR-Cas13 enzyme, which can detect RNA from viruses and cells — ...

Good morning. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm. On stage, we have Sam from ...